Kavuru; Padmini

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kavuru; Padmini.The latest application filed is for "niraparib solid state form".

Company Profile

6.10.15

Kavuru; Padmini - Townsend MA
KAVURU; Padmini - Devens MA
Kavuru; Padmini - Fitchburg MA
Kavuru; Padmini - West Lafayette IN US
Kavuru; Padmini - Lakeland FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline forms of dasatinib Grant 11,440,908 - Kavuru September 13, 2	2022-09-13
Niraparib Solid State Form App 20210221787 - KAVURU; Padmini	2021-07-22
Crystalline Forms Of Dasatinib App 20210032235 - KAVURU; Padmini	2021-02-04
Solid-state Forms Of Regadenoson, Their Use And Preparation App 20210009626 - KAVURU; Padmini	2021-01-14
Nutraceutical co-crystal compositions Grant 10,842,797 - Zaworotko , et al. November 24, 2	2020-11-24
Forms of apremilast Grant 10,730,836 - Kavuru	2020-08-04
Pharmaceutically Acceptable Salts Of Beta-guanidinopropionic Acid With Improved Properties And Uses Thereof App 20200138759 - MARTINEZ; Eduardo J. ; et al.	2020-05-07
Novel Forms Of Apremilast App 20200010416 - KAVURU; Padmini	2020-01-09
Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof Grant 10,512,623 - Martinez , et al. Dec	2019-12-24
Nutraceutical Co-crystal Compositions App 20190275056 - ZAWOROTKO; Michael John ; et al.	2019-09-12
Nutraceutical co-crystal compositions Grant 10,376,521 - Zaworotko , et al. A	2019-08-13
Novel Forms Of Apremilast App 20190106389 - KAVURU; Padmini	2019-04-11
Forms of apremilast Grant 10,196,355 - Kavuru Fe	2019-02-05
Lithium cocrystal compositions Grant 10,130,708 - Zaworotko , et al. November 20, 2	2018-11-20
Pharmaceutically Acceptable Salts Of B-guanidinopropionic Acid With Improved Properties And Uses Thereof App 20180243248 - MARTINEZ; Eduardo J. ; et al.	2018-08-30
Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof Grant 9,884,813 - Martinez , et al. February 6, 2	2018-02-06
Novel Forms Of Apremilast App 20170362175 - KAVURU; Padmini	2017-12-21
Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof Grant 9,827,217 - Martinez , et al. November 28, 2	2017-11-28
PHARMACEUTICALLY ACCEPTABLE SALTS OF ss-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF App 20170056353 - MARTINEZ; Eduardo J. ; et al.	2017-03-02
PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF App 20170056352 - MARTINEZ; Eduardo J. ; et al.	2017-03-02
Nutraceutical Co-crystal Compositions App 20150250797 - ZAWOROTKO; Michael John ; et al.	2015-09-10
Lithium Compositions App 20140242193 - Zaworotko; Michael John ; et al.	2014-08-28
Nutraceutical Co-crystal Compositions App 20100204204 - Zaworotko; Michael ; et al.	2010-08-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.